Chugai Pharmaceutical Co., Ltd. - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
CHGCY Over the counter 2830 www.chugai-pharm.co.jp

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Chugai Pharmaceutical Co., Ltd.

Chugai Pharmaceutical (TSE:4519) Stock Price Trails Strong Q3 Earnings - Oct 29th, 2026 12:28 am
Chugai expects full-year results to beat forecast as drug exports and royalties gr - Oct 27th, 2026 2:56 am
Chugai Pharmaceutical (TSE:4519) Stock May Be Cheap On Cash Flow - Oct 25th, 2026 2:13 am
Rani Therapeutics Eyes 2027 Obesity Data as Oral Biologics Platform Advances - Oct 21st, 2026 8:02 pm
Will Regaining Emugrobart Rights and Refocusing on SMA Change Chugai Pharmaceutical's (TSE:4519) Narrative - Oct 5th, 2026 11:06 am
Oil Bills, Bond Yields, Tech Jitters Damp Asian Stock Markets - Sep 29th, 2026 4:47 am
Chugai Pharmaceutical And 2 Japanese AI Healthcare Stocks To Own - Sep 25th, 2026 6:13 pm
Three Chugai Researchers Behind the Discovery of Hemlibra for Hemophilia A Receive Prestigious U.S. Lasker Award, One of the World’s Most Respected Scientific Honors - Sep 9th, 2026 7:45 am
Autoimmune Uveitis Market to Expand at a CAGR of 7% During the Forecast Period (2026-2036) as Novel Treatments Challenge the Existing Therapeutic Landscape | DelveInsight - Sep 2nd, 2026 8:31 am
3 Japanese AI Healthcare Stocks Investors May Want To Watch - Aug 26th, 2026 10:39 pm
RG-6299 Sales Forecast, and Market Size Analysis - 2034 Released — Examines Mechanism, Dosing, Pricing, Patents, and Emerging Competitors - Aug 17th, 2026 3:46 am
Travere Therapeutics Inc (TVTX) (Q2 2026) Earnings Call Highlights: Record FILSPARI Demand and ... - Aug 4th, 2026 11:05 pm
Phylo and Chugai partner to advance AI agents in drug discovery - Aug 4th, 2026 10:00 am
Rani Therapeutics Announces the Promotion of Alireza Javadi, Ph.D. to Chief Technical Officer - Jan 28th, 2026 5:00 am